Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Oct 13, 2026

IMMX — Immix Biopharma, Inc. Dilution Risk Tracker

Track IMMX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMMX — Get alerts when the score changes →

As of October 13, 2026, Immix Biopharma, Inc. (IMMX) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Immix Biopharma, Inc. has a market capitalization of $661.74M, 71.54M shares outstanding, 77 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for IMMX.
🔔 Track IMMX — Get forecast alerts →

Market Data

Market Cap$661.74M
Shares Outstanding71.54M
Float40.34M
Cash$232.11M
Debt$1.04M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore37/100DilutionWatch score record
Shares Outstanding71.54MVerified float table or market cache
Public Float40.34MVerified float table or market cache
Market Cap$661.74MMarket data cache
Cash Runway159.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 34.2% shares (2026Q1 vs prior)
77 institutional holders · 34.24M shares
#1 JANUS HENDERSON GROUP PLC 9.60M shares
#2 Saturn V Capital Management LP 3.69M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.58M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.39M
Days to Cover5.1
% of Float25.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-05-07
xbrl XBRL CONVERTIBLE 2023-03-27
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual IMMX Dilution Snapshot

Immix Biopharma, Inc. (IMMX) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

IMMX's DilutionScore is currently 37/100 (Medium risk), with 5 score changes tracked over 89 days. The score deteriorated from 42/100 (Medium risk).

Period Score Risk Level Duration
Oct 03 – Oct 13, 202637/100MEDIUM11 days
Sep 30 – Oct 02, 202642/100MEDIUM3 days
Aug 22 – Sep 29, 202639/100MEDIUM39 days
Aug 14 – Aug 21, 202640/100MEDIUM7 days
Jul 17 – Aug 13, 202636/100MEDIUM28 days
Jul 16, 202635/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

IMMX shares outstanding have increased 2.8% from 52.96M (Mar 2026) to 54.41M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 10, 202654.41M40.34M▲ 2.73%
May 08, 202653.01M39.26M▲ 7.71%
Apr 11, 202653.01M36.45M▲ 0.04%
Mar 29, 202652.96M36.44M▲ 0.23%
Mar 27, 202652.96M36.35M▲ 57.74%
Mar 23, 202652.96M23.05M▼ 7.21%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track IMMX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment IMMX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking IMMX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IMMX
IMMX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.